Alleviation of Post-COVID-19 Cognitive Deficits by Treatment with EGb 761®: A Case Series

26 September 2022 : Case report Austria

Unusual or unexpected effect of treatment

Udo A. Zifko^1E*, Muhammad Yacob^1E, Benedikt J. Braun^1BE, Gunnar P.H. Dietz^2EF

DOI: 10.12659/AJCR.937094

Am J Case Rep 2022; 23:e937094

Background Case Reports Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Table 1. Demographic data and baseline neurological symptoms from all 5 patients.

Female	60%
Average age (range)	34.6 (26–59) years
Average time from infection to first outpatient visit	19.4 (9–35) weeks
Neurological symptoms	Fatigue 4/5
	Headache 2/5
	Hyposmia 3/5
	Depressive mood 2/5
	Position tremor 1/5
	Autonomic dysfunction 1/5

Back to the Article